Finland· FI-REL-REL3474
Contralac Vet
A metergoliini product containing metergoline, registered in Finland by Virbac.
Checked against Fimea (Finland) on
Informational only — not a medical device.
The record
At a glance
Fimea (Finland)- Active substance
- Metergoline
- Manufacturer
- Virbac
- Country
- Finland (FI)
- ATC code
- QG02CB05
- ATC class
- Metergoliini
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Metergoline in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Liserdol
- Italy · Liserdol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4874814-5a5d-41f6-b1f8-1f8366ebe3cc GET /v1/drugs/f4874814-5a5d-41f6-b1f8-1f8366ebe3cc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti",
"route": null,
"ddd_unit": null,
"strength": "2 mg",
"atc_label": "Metergoliini",
"ma_number": "11470",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL3474",
"authorised_at": "1994-05-18"
}See everything about metergoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.